U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219407) titled 'A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures' on Oct. 08.
Brief Summary: This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.
Study Start Date: Nov. 03
Study Type: INTERVENTIONAL
Condition:
Focal Epilepsy
Epilepsy
Refractory Focal Epilepsy
Seizure
Focal Seizure
Focal Onset Seizure
Intervention:
DRUG: RAP-219
Participants will receive one RAP-219 0.125 mg capsule...